Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how early high-efficacy disease modifying therapies (DMTs) are linked to better outcomes in patients with Relapsing-Remitting Multiple Sclerosis (RRMS) and reads “MS Doesn’t Get to Decide Whether We Are Enough”, a column by Jennifer Powell.

===================================

Treatment for Relapsing MS Progression | MAYZENT® (siponimod)

Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/